Financial Performance - Total revenue for the first half of 2024 reached RMB 829.0 million, a 6.6% increase compared to RMB 777.9 million in the same period of 2023[2] - Net profit attributable to shareholders for the first half of 2024 was RMB 50.7 million, reflecting a 15.9% increase from RMB 43.8 million in the previous year[3] - Operating income from self-owned hospitals amounted to RMB 765.6 million, up 5.1% year-on-year[3] - The overall gross profit increased to RMB 226.2 million, reflecting a growth of 12.2% compared to 2023[7] - The cash generated from operating activities was RMB 116.5 million, a 2.6% increase compared to the same period in 2023[7] - The company achieved revenue of RMB 829.0 million, a 6.6% increase compared to the same period in 2023[7] - The total revenue from treatment and general medical services was RMB 617.7 million, an increase of 5.2% year-on-year[11] - Total operating revenue for the six months ended June 30, 2024, was RMB 828,957,554, an increase from RMB 777,925,164 for the same period in 2023, reflecting a growth of approximately 6.5%[70] - Total profit for the first half of 2024 reached CNY 61,512,576, up from CNY 60,207,112 in 2023, indicating a growth of about 2.2%[73] Operational Highlights - The total number of self-owned hospitals remained at 32, with an increase in operational bed count to 11,648 from 11,268 as of December 31, 2023[3] - Revenue from elderly care services reached approximately RMB 238.1 million, accounting for 31.1% of the operating income from self-owned hospitals[6] - The group opened 6 elderly hospitals and has 1 ongoing health care project, with around 2,730 beds available[6] - The company's self-operated hospital billing revenue was RMB 784.9 million, a 5.5% increase year-on-year, driven by increased outpatient and inpatient visits[9] - The average bed occupancy rate for inpatient services improved to 87.4%, up from 84.0% in the previous year[10] - The company expanded its hospital bed capacity to 11,648 beds, an increase from 10,578 beds in the previous year[10] Financial Position - Total assets as of June 30, 2024, were RMB 3,008.4 million, a slight decrease from RMB 3,047.7 million at the end of 2023[2] - Total liabilities decreased to RMB 1,581.9 million from RMB 1,639.5 million at the end of 2023[2] - As of June 30, 2024, inventory balance was RMB 519 million, down from RMB 606 million as of December 31, 2023[28] - Accounts receivable balance increased to RMB 4,481 million, a growth of 6.6% from RMB 4,204 million as of December 31, 2023, mainly due to increased operating income from self-owned hospitals[29] - The group’s debt-to-asset ratio slightly decreased to 52.6% from 53.8% as of December 31, 2023[48] - The company reported cash and cash equivalents of CNY 373,302,433 as of June 30, 2024, down from CNY 418,861,721 at the end of 2023, a decrease of about 10.9%[76] Expenses and Costs - The group's self-owned hospital operating costs increased to RMB 555.2 million, a slight increase of 1.4% compared to RMB 547.5 million in the same period of 2023[13] - Employee benefits and expenses accounted for 41.1% of self-owned hospital operating costs, up from 38.1% in the same period of 2023[14] - Management expenses totaled RMB 106.3 million, a 4.3% increase from RMB 101.9 million in the same period of 2023, with employee benefits and expenses rising by 15.1%[20] - Research and development expenses rose to RMB 17.6 million, a 17.6% increase from RMB 15.0 million in the same period of 2023, representing 2.3% of self-owned hospital operating revenue[21] - Financial expenses net amount was RMB 24.5 million, an increase of RMB 4.3 million compared to the same period in 2023, primarily due to an increase in borrowing interest expenses[23] Shareholder Information - The company proposed a mid-term dividend of RMB 1.50 per 10 shares, totaling approximately RMB 11,077,260, which represents 21.8% of the net profit attributable to shareholders for the reporting period[65] - Basic and diluted earnings per share for the first half of 2024 were both CNY 0.68, compared to CNY 0.59 in the same period of 2023, marking an increase of about 15.3%[75] - The proposed cash dividend for the interim profit distribution is RMB 1.50 per 10 shares, amounting to a total of RMB 11,077,260 based on the current share capital[94] Strategic Initiatives - The group aims to enhance operational management and adapt to new policies in the healthcare sector, focusing on mental health and elderly care as core business areas[6] - The group is actively adjusting operational strategies in response to underperforming hospitals due to local healthcare insurance settlement discrepancies[4] - The company plans to expand its market presence and invest in new product development, although specific figures were not disclosed[86] - The company’s strategy includes potential mergers and acquisitions to enhance growth opportunities in the future[86] Compliance and Governance - The audit committee has reviewed the interim performance announcement and confirmed compliance with applicable accounting standards and regulations[64] - The company has complied with all corporate governance codes during the reporting period[67] - The financial statements are prepared in accordance with the Chinese Accounting Standards and are consistent with the accounting policies used for the 2023 annual financial statements[69] Employee Information - The group employed 4,742 employees as of June 30, 2024, a decrease from 4,765 employees as of December 31, 2023[49] - Employee compensation for the reporting period was approximately RMB 313.8 million, compared to RMB 291.5 million for the six months ended June 30, 2023[49] - The average employee compensation, including social insurance and housing fund contributions, was RMB 132.4 thousand per year[49]
康宁医院(02120) - 2024 - 年度业绩